Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC

12/02/2021 | 05:29pm EST

Dec 2 (Reuters) - The United States has administered 464,445,580 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 578,263,565 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 462,263,845 vaccine doses the CDC said had gone into arms by Dec. 1 out of 575,721,925 doses delivered.

The agency said 234,269,053 people had received at least one dose while 197,838,728 people are fully vaccinated as of 6:00 a.m. ET on Thursday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 43.0 million people received a booster dose of COVID-19 vaccine from either Pfizer or Moderna or J&J. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)


ę Reuters 2021
All news about MODERNA, INC.
02:14pUS Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
11:05aPrescription drugs, medical devices boost J&J in Q4
AQ
10:58aEMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Inc..
RE
06:33aJ&J expects jump in COVID vaccine sales in 2022, eyes device deals
RE
04:31aGermany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24LEIDEN UNIVERSITY : mRNA boosters are the most effective upon receiving Janssen vaccinatio..
AQ
01/24INSIDER SELL : Moderna
MT
01/24NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
DJ
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 644 M - -
Net income 2021 11 173 M - -
Net cash 2021 10 558 M - -
P/E ratio 2021 5,92x
Yield 2021 -
Capitalization 63 777 M 63 777 M -
EV / Sales 2021 3,02x
EV / Sales 2022 1,97x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 157,30 $
Average target price 266,88 $
Spread / Average Target 69,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842
CELLTRION, INC.-19.95%19 358